Further, a role of GLO1 in cancer cell chemoresistance has been demonstrated, and the development of pharmacological and genetic strategies modulating GLO1 for experimental cancer therapy has attracted significant attention [8,9,10,11,12]. This evidence concerns the gene GLO1 and cancer.